This Article Full Text Full Text (PDF) Erratum Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bruehl, H. Articles by Convit, A. Search for Related Content PubMed PubMed Citation Articles by Bruehl, H. Articles by Convit, A. Related Collections Adrenal and Hypertension Neuroendocrinology and Pituitary

Hypothalamic-Pituitary-Adrenal Axis Dysregulation and Memory Impairments in Type 2 Diabetes

Department of Psychiatry (H.B., M.R., I.D., V.S., A.T., E.J., A.A., A.C.), New York University School of Medicine, New York, New York 10016; Department of Psychology (O.T.W.), University of Bielefeld, D-33501 Bielefeld, Germany; and Nathan Kline Institute for Psychiatric Research (A.C.), Orangeburg, New York 10962

Address all correspondence and requests for reprints to: Antonio Convit, M.D., Center for Brain Health, HN-400, New York University School of Medicine, 550 First Avenue, New York, New York 10016. E-mail: antonio.convit{at}med.nyu.edu.

Context: There is evidence of both hypothalamic-pituitary-adrenocortical (HPA) axis and cognitive dysfunction in type 2 diabetes mellitus (T2DM). However, the exact nature and the associations between these abnormalities remain unclear.

Objectives: The aim of the study was to characterize the nature of the HPA dysregulation in T2DM and ascertain whether impaired cognition in T2DM could be attributed to these abnormalities.

Design: A cross-sectional study was performed, contrasting matched groups on HPA axis function and cognition by using the combined dexamethasone (DEX)/CRH test and a neuropsychological battery assessing declarative and working memory, attention, and executive function.

Setting: The study was conducted in a research clinic in an academic medical center.

Participants: Participants were volunteers functioning in the cognitively normal range. We studied 30 middle-aged individuals with T2DM, on average 7.5 yr since diabetes diagnosis, and 30 age-, gender-, and education-matched controls.

Main Outcome Measures: Basal cortisol levels, cortisol levels during the DEX/CRH test, and performance on neuropsychological tests were measured.

Results: Individuals with T2DM had elevated basal plasma cortisol levels, higher levels after DEX suppression, and a larger response to CRH (all P 0.005). Among individuals with T2DM, cortisol levels during the DEX/CRH test were positively associated with glycosylated hemoglobin (P = 0.05), independent of age, body mass index, hypertension, and dyslipidemia. Diabetic subjects showed cognitive impairments restricted to declarative memory. Across all subjects, declarative memory was inversely associated with cortisol levels; however, these associations were subsumed by glycemic control (glycosylated hemoglobin).

Conclusions: HPA hyperactivity and declarative memory deficits are present in T2DM. Both alterations may reflect the negative impact of poor glycemic control on the hippocampal formation.

This article has been cited by other articles:

				S. Kopprasch, J. Pietzsch, I. Ansurudeen, J. Graessler, A. W Krug, M. Ehrhart-Bornstein, and S. R Bornstein Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion J. Endocrinol., January 1, 2009; 200(1): 45 - 52. [Abstract] [Full Text] [PDF]

				M. W. J. Strachan, R. M. Reynolds, B. M. Frier, R. J. Mitchell, and J. F. Price The relationship between type 2 diabetes and dementia Br. Med. Bull., December 1, 2008; 88(1): 131 - 146. [Abstract] [Full Text] [PDF]